These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


909 related items for PubMed ID: 4997629

  • 21. [Preliminary studies of the antithymocyte globulin].
    Orlowski T, Skopińska E, Kossowska-Paul B, Wasik M, Wojtulewicz-Kurkus J, Klopotowska E, Tupalska B, Filipowicz Z.
    Pol Arch Med Wewn; 1970; 45(2):237-44. PubMed ID: 4919363
    [No Abstract] [Full Text] [Related]

  • 22. Analyses of histocompatibility in cadaver renal transplantation.
    Morris PJ.
    Transplant Proc; 1971 Jun; 3(2):1030-5. PubMed ID: 4944045
    [No Abstract] [Full Text] [Related]

  • 23. Studies on heterologous antilymphocyte serum in mice. VII. Optimal cellular antigen for induction of immunologic tolerance with antilymphocyte serum.
    Monaco AP, Wood ML.
    Transplant Proc; 1970 Dec; 2(4):489-96. PubMed ID: 4939696
    [No Abstract] [Full Text] [Related]

  • 24. The effects of heterologous anti-thymocyte sera in mice. II. Quantitative evaluation of IgM, IgG, and their subunits in suppressing homograft reactions.
    Mandel MA, Asofsky R.
    J Immunol; 1968 Jun; 100(6):1259-67. PubMed ID: 4880144
    [No Abstract] [Full Text] [Related]

  • 25. Prednisone used as treatment for rejection correlates with poor outcome.
    Toussaint RM, Callender CO, Dunston GM, Flores J, Walters CS, John D, Yeager C, Bond O, Thompson C, Gear JC.
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1712-5. PubMed ID: 2652561
    [No Abstract] [Full Text] [Related]

  • 26. Studies on the decline in immunosuppressive potency of rabbit anti-mouse thymocyte sera raised by repeated immunization of the same rabbit.
    Ponsford FM, Symes MO.
    Folia Biol (Praha); 1971 Feb; 17(4):227-35. PubMed ID: 5002373
    [No Abstract] [Full Text] [Related]

  • 27. Survey of the current status of the clinical uses of antilymphocyte serum.
    Monaco AP, Codish SD.
    Surg Gynecol Obstet; 1976 Mar; 142(3):417-26. PubMed ID: 766248
    [Abstract] [Full Text] [Related]

  • 28. A new in vitro assay for immunosuppressive potency of antilymphocyte serum.
    Gozzo JJ, Wood ML, Pompei R, Monaco AP.
    Transplant Proc; 1972 Dec; 4(4):481-5. PubMed ID: 4566791
    [No Abstract] [Full Text] [Related]

  • 29. Rejection of renal allografts in man.
    Orlowski T, Gradowska L, Kardasiewicz W, Rowińska D.
    Pol Med J; 1971 Dec; 10(2):371-86. PubMed ID: 4104329
    [No Abstract] [Full Text] [Related]

  • 30. Solubilization of lymphocyte and thymocyte antigens by a reversible chemical modification.
    Eshhar Z, Gafni M, Givol D, Sela M.
    Eur J Immunol; 1971 Nov; 1(5):323-9. PubMed ID: 4945634
    [No Abstract] [Full Text] [Related]

  • 31. Clinical use of antilymphoblast serum.
    Najarian JS, Merkel FK, Moore GE, Good RA, Aust JC.
    Transplant Proc; 1969 Mar; 1(1):460-2. PubMed ID: 5002662
    [No Abstract] [Full Text] [Related]

  • 32. Experimental and clinical use of antilymphocytic serum in kidney transplantation.
    Zühlke V, Marchioro TL, Starzi TE.
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1969 Mar; ():Suppl:469-76. PubMed ID: 4896594
    [No Abstract] [Full Text] [Related]

  • 33. A standardized ALG for use in man.
    Thomas J, Hume DM.
    Transplant Proc; 1972 Dec; 4(4):477-9. PubMed ID: 4118964
    [No Abstract] [Full Text] [Related]

  • 34. Use of rabbit ATG in cadaver kidney transplantation: an updated report with consideration of presensitized recipients.
    Davis RC, Nabseth DC, Olsson CA, Idelson BA, Schmitt GW, Cho SI, Mannick JA.
    Transplant Proc; 1974 Dec; 6(4 Suppl 1):67-70. PubMed ID: 4612906
    [No Abstract] [Full Text] [Related]

  • 35. Comparative studies on the characteristics of the antilymphocyte sera.
    Gościcka T, Rudnicka W, Zablocki B.
    Pol Med J; 1971 Dec; 10(2):320-6. PubMed ID: 5558507
    [No Abstract] [Full Text] [Related]

  • 36. [Follow-ups after kidney transplantations].
    Halbfass HJ, Staib I, Heinze V, Jontofsohn R, Junkers K.
    Dtsch Med Wochenschr; 1973 Mar 09; 98(10):479-81. PubMed ID: 4570868
    [No Abstract] [Full Text] [Related]

  • 37. [Immunosuppression by means of antilymphocyte serums in humans].
    Revillard JP.
    Nouv Rev Fr Hematol; 1972 Mar 09; 12(2):129-37. PubMed ID: 4264610
    [No Abstract] [Full Text] [Related]

  • 38. The effects of administration of heterologous antithymus serum to New Zealand rabbits.
    Bitterman W, Shorter RG.
    Exp Med Surg; 1968 Mar 09; 26(1-2):43-51. PubMed ID: 4180639
    [No Abstract] [Full Text] [Related]

  • 39. Use of antithymocyte globulin in human heart transplantation.
    Griepp RB, Stinson EB, Dong E, Phillips RC, Morrell RM, Shumway NE.
    Circulation; 1972 May 09; 45(5 Suppl 1):I147-53. PubMed ID: 4554349
    [No Abstract] [Full Text] [Related]

  • 40. [Experimental and clinical administration of cytotoxic antilymphocyte serum and antilymphocyte globulin in homologous skin transplantation].
    Spasokukots'kii IuO, Gorodets'ka SF, Timoshenko IuG.
    Fiziol Zh; 1971 May 09; 17(3):341-5. PubMed ID: 4118041
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 46.